anmelden
FTSE All-Share
5.850,42
PKT
+17,79
PKT
+0,31
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 10.03.22 | Rio Tinto Hold | Jefferies & Company Inc. | |
| 10.03.22 | BP Overweight | JP Morgan Chase & Co. | |
| 10.03.22 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 09.03.22 | Vodafone Group Outperform | Bernstein Research | |
| 09.03.22 | Prudential Buy | Jefferies & Company Inc. | |
| 09.03.22 | Prudential Buy | Deutsche Bank AG | |
| 09.03.22 | Prudential Overweight | Barclays Capital | |
| 09.03.22 | Vodafone Group Overweight | Barclays Capital | |
| 09.03.22 | Prudential Overweight | JP Morgan Chase & Co. | |
| 08.03.22 | HSBC Outperform | RBC Capital Markets | |
| 08.03.22 | Rio Tinto Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.03.22 | Barclays Outperform | Credit Suisse Group | |
| 08.03.22 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.03.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 08.03.22 | Lloyds Banking Group Overweight | Barclays Capital | |
| 08.03.22 | Imperial Brands Overweight | Barclays Capital | |
| 08.03.22 | BAT Overweight | Barclays Capital | |
| 07.03.22 | AstraZeneca Buy | UBS AG | |
| 07.03.22 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 07.03.22 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.03.22 | Unilever Sell | UBS AG | |
| 04.03.22 | London Stock Exchange (LSE) Hold | Deutsche Bank AG | |
| 03.03.22 | HSBC Outperform | RBC Capital Markets | |
| 03.03.22 | HSBC Neutral | Credit Suisse Group | |
| 03.03.22 | London Stock Exchange (LSE) Neutral | UBS AG | |
| 03.03.22 | Prudential Overweight | JP Morgan Chase & Co. | |
| 02.03.22 | Diageo Neutral | JP Morgan Chase & Co. | |
| 01.03.22 | BP Conviction Buy List | Goldman Sachs Group Inc. | |
| 01.03.22 | GSK Neutral | UBS AG | |
| 01.03.22 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 01.03.22 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 28.02.22 | BP Hold | Jefferies & Company Inc. | |
| 28.02.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 28.02.22 | Barclays Sector Perform | RBC Capital Markets | |
| 28.02.22 | BP Overweight | Barclays Capital | |
| 28.02.22 | HSBC Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 28.02.22 | BP Overweight | JP Morgan Chase & Co. | |
| 28.02.22 | BP Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.02.22 | BP Outperform | RBC Capital Markets | |
| 25.02.22 | BAE Systems Neutral | JP Morgan Chase & Co. |
